JP Stock MarketDetailed Quotes

4577 Daito Pharmaceutical

Watchlist

2157
+10+0.47%

20min DelayTrading Nov 25 11:30 JST

33.11BMarket Cap10.27P/E (Static)

Daito Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Aug 31, 2024

(FY)May 31, 2024

(Q4)May 31, 2024

(Q3)Feb 29, 2024

(Q2)Nov 30, 2023

(Q1)Aug 31, 2023

(FY)May 31, 2023

(Q4)May 31, 2023

(Q3)Feb 28, 2023

(Q2)Nov 30, 2022

Total revenue

4.11%12.68B

3.98%46.9B

16.16%12.23B

-5.81%10.55B

5.35%11.93B

1.14%12.18B

3.77%45.1B

6.58%10.53B

0.75%11.2B

5.68%11.33B

Cost of revenue

7.47%10.43B

6.57%37.06B

18.71%9.69B

-2.44%8.45B

6.10%9.22B

4.75%9.7B

8.64%34.77B

8.21%8.16B

7.45%8.66B

9.49%8.69B

Gross profit

-9.09%2.25B

-4.76%9.84B

7.39%2.54B

-17.25%2.11B

2.84%2.72B

-10.91%2.47B

-9.84%10.33B

1.33%2.37B

-16.88%2.55B

-5.10%2.64B

Operating expense

0.50%1.4B

16.05%5.95B

38.52%1.76B

1.90%1.29B

14.60%1.51B

9.25%1.39B

4.44%5.12B

-11.46%1.27B

-2.09%1.27B

3.95%1.32B

Operating profit

-21.46%849M

-25.23%3.89B

-28.40%789M

-36.20%816M

-8.83%1.21B

-28.03%1.08B

-20.52%5.21B

21.50%1.1B

-27.70%1.28B

-12.66%1.33B

Net non-operating interest income (expenses)

-466.67%-17M

-241.67%-41M

-375.00%-19M

-333.33%-13M

-200.00%-6M

0.00%-3M

-33.33%-12M

-100.00%-4M

0.00%-3M

0.00%-2M

Non-operating interest income

--0

---3M

--1M

--2M

Non-operating interest expense

466.67%17M

241.67%41M

1,800.00%19M

225.00%13M

50.00%6M

0.00%3M

33.33%12M

-50.00%1M

33.33%4M

100.00%4M

Net investment income

750.00%85M

223.53%42M

193.75%15M

-64.15%19M

95.83%-2M

143.48%10M

-144.16%-34M

-366.67%-16M

39.47%53M

-1,700.00%-48M

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

409M

326M

1,058.82%326M

170.65%65M

-34M

Income from associates and other participating interests

63M

Special income (charges)

96.77%-3M

88.46%-9M

-9M

236.36%15M

-681.25%-93M

-333.33%-78M

-11M

Less:Other special charges

----

-96.77%3M

-88.46%9M

--9M

----

4,750.00%93M

143.75%78M

--0

--11M

Other non-operating income (expenses)

-80.00%1M

-71.43%2M

-66.67%3M

-200.00%-12M

150.00%5M

-80.00%7M

0.00%9M

78.95%-4M

Income before tax

27.47%1.39B

-16.90%4.22B

-27.96%778M

-12.86%1.13B

-0.97%1.22B

-25.71%1.09B

-24.46%5.08B

33.17%1.08B

-28.79%1.29B

-15.06%1.24B

Income tax

113.05%914M

-32.86%1.04B

-175.14%-130M

-11.65%349M

-10.30%392M

-21.14%429M

-25.96%1.55B

31.06%173M

-36.80%395M

-14.48%437M

Net income

-28.05%477M

-9.90%3.18B

0.00%908M

-13.30%776M

4.14%831M

-28.40%663M

-23.77%3.53B

33.73%908M

-24.66%895M

-15.38%798M

Net income continuous operations

-27.90%478M

-9.90%3.18B

0.11%908M

-13.39%776M

4.14%831M

-28.40%663M

-23.79%3.53B

33.58%907M

-24.58%896M

-15.38%798M

Noncontrolling interests

-600.00%-140M

-61.11%-116M

-50.00%-48M

-266.67%-11M

-105.56%-37M

-5.26%-20M

-80.00%-72M

-190.91%-32M

76.92%-3M

-100.00%-18M

Net income attributable to the company

-9.52%618M

-8.47%3.3B

1.70%956M

-12.36%787M

6.50%869M

-27.80%683M

-22.88%3.6B

36.23%940M

-25.23%898M

-14.29%816M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-9.52%618M

-8.47%3.3B

1.70%956M

-12.36%787M

6.50%869M

-27.80%683M

-22.88%3.6B

36.23%940M

-25.23%898M

-14.29%816M

Gross dividend payment

Basic earnings per share

-6.59%40.42

-7.75%210

3.67%61.65

-11.79%50.13

6.51%54.95

-27.57%43.27

-25.35%227.63

37.43%59.47

-27.11%56.83

-17.71%51.59

Diluted earnings per share

-6.59%40.42

-7.66%210

3.68%61.65

-11.79%50.13

6.50%54.8196

-27.57%43.27

-25.42%227.42

37.41%59.46

-26.91%56.83

-17.80%51.4754

Dividend per share

10.00%60

10.00%30

20.00%54.5455

20.00%27.2727

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q1)Aug 31, 2024	(FY)May 31, 2024	(Q4)May 31, 2024	(Q3)Feb 29, 2024	(Q2)Nov 30, 2023	(Q1)Aug 31, 2023	(FY)May 31, 2023	(Q4)May 31, 2023	(Q3)Feb 28, 2023	(Q2)Nov 30, 2022
Total revenue	4.11%12.68B	3.98%46.9B	16.16%12.23B	-5.81%10.55B	5.35%11.93B	1.14%12.18B	3.77%45.1B	6.58%10.53B	0.75%11.2B	5.68%11.33B
Cost of revenue	7.47%10.43B	6.57%37.06B	18.71%9.69B	-2.44%8.45B	6.10%9.22B	4.75%9.7B	8.64%34.77B	8.21%8.16B	7.45%8.66B	9.49%8.69B
Gross profit	-9.09%2.25B	-4.76%9.84B	7.39%2.54B	-17.25%2.11B	2.84%2.72B	-10.91%2.47B	-9.84%10.33B	1.33%2.37B	-16.88%2.55B	-5.10%2.64B
Operating expense	0.50%1.4B	16.05%5.95B	38.52%1.76B	1.90%1.29B	14.60%1.51B	9.25%1.39B	4.44%5.12B	-11.46%1.27B	-2.09%1.27B	3.95%1.32B
Operating profit	-21.46%849M	-25.23%3.89B	-28.40%789M	-36.20%816M	-8.83%1.21B	-28.03%1.08B	-20.52%5.21B	21.50%1.1B	-27.70%1.28B	-12.66%1.33B
Net non-operating interest income (expenses)	-466.67%-17M	-241.67%-41M	-375.00%-19M	-333.33%-13M	-200.00%-6M	0.00%-3M	-33.33%-12M	-100.00%-4M	0.00%-3M	0.00%-2M
Non-operating interest income	--0	--0	--0	--0	--0	--0	--0	---3M	--1M	--2M
Non-operating interest expense	466.67%17M	241.67%41M	1,800.00%19M	225.00%13M	50.00%6M	0.00%3M	33.33%12M	-50.00%1M	33.33%4M	100.00%4M
Net investment income	750.00%85M	223.53%42M	193.75%15M	-64.15%19M	95.83%-2M	143.48%10M	-144.16%-34M	-366.67%-16M	39.47%53M	-1,700.00%-48M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets	409M	326M	0	1,058.82%326M			0	170.65%65M	-34M
Income from associates and other participating interests	63M
Special income (charges)	0	96.77%-3M	88.46%-9M	-9M	236.36%15M	0	-681.25%-93M	-333.33%-78M	0	-11M
Less:Other special charges	----	-96.77%3M	-88.46%9M	--9M	----	----	4,750.00%93M	143.75%78M	--0	--11M
Other non-operating income (expenses)	-80.00%1M	-71.43%2M	-66.67%3M	-200.00%-12M	6M	150.00%5M	-80.00%7M	0.00%9M	78.95%-4M	0
Income before tax	27.47%1.39B	-16.90%4.22B	-27.96%778M	-12.86%1.13B	-0.97%1.22B	-25.71%1.09B	-24.46%5.08B	33.17%1.08B	-28.79%1.29B	-15.06%1.24B
Income tax	113.05%914M	-32.86%1.04B	-175.14%-130M	-11.65%349M	-10.30%392M	-21.14%429M	-25.96%1.55B	31.06%173M	-36.80%395M	-14.48%437M
Net income	-28.05%477M	-9.90%3.18B	0.00%908M	-13.30%776M	4.14%831M	-28.40%663M	-23.77%3.53B	33.73%908M	-24.66%895M	-15.38%798M
Net income continuous operations	-27.90%478M	-9.90%3.18B	0.11%908M	-13.39%776M	4.14%831M	-28.40%663M	-23.79%3.53B	33.58%907M	-24.58%896M	-15.38%798M
Noncontrolling interests	-600.00%-140M	-61.11%-116M	-50.00%-48M	-266.67%-11M	-105.56%-37M	-5.26%-20M	-80.00%-72M	-190.91%-32M	76.92%-3M	-100.00%-18M
Net income attributable to the company	-9.52%618M	-8.47%3.3B	1.70%956M	-12.36%787M	6.50%869M	-27.80%683M	-22.88%3.6B	36.23%940M	-25.23%898M	-14.29%816M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	-9.52%618M	-8.47%3.3B	1.70%956M	-12.36%787M	6.50%869M	-27.80%683M	-22.88%3.6B	36.23%940M	-25.23%898M	-14.29%816M
Gross dividend payment
Basic earnings per share	-6.59%40.42	-7.75%210	3.67%61.65	-11.79%50.13	6.51%54.95	-27.57%43.27	-25.35%227.63	37.43%59.47	-27.11%56.83	-17.71%51.59
Diluted earnings per share	-6.59%40.42	-7.66%210	3.68%61.65	-11.79%50.13	6.50%54.8196	-27.57%43.27	-25.42%227.42	37.41%59.46	-26.91%56.83	-17.80%51.4754
Dividend per share	0	10.00%60	10.00%30	0	10.00%30	0	20.00%54.5455	20.00%27.2727	0	20.00%27.2727
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data